Decoy Therapeutics is trading at $5.61 (6.3%) down in after-hours trading, following a 3.1% decline during the regular session to $5.99.

  • The move comes despite a lack of fresh company-specific headlines, earnings releases, or major filings today to serve as a direct catalyst.
  • Shares appear to be tracking broader market sentiment as indices like the Nasdaq also faced downward pressure.
  • Recent volatility following prior financing news may be continuing to weigh on investor sentiment.